1940nm波长早期静脉腔内激光消融治疗儿童KTS边缘静脉的4年回顾性队列研究
本研究为单中心回顾性单臂队列,纳入44例儿童KTS患者(平均年龄12.5岁),针对有症状的边缘静脉功能不全行1940nm波长EVLA。技术成功率100%,4年静脉生活质量评分从828.4升至1562.1(P<.001),腿围和大腿围分别减少8.1cm和8.9cm(P<.001),晚期再通率4.5%,无深静脉血栓或肺栓塞。
要点
- 1940nm EVLA治疗儿童KTS边缘静脉技术成功率100%,4年晚期再通率仅4.5%。
- 术后4年静脉生活质量评分显著提高,腿围和大腿围分别减少8.1cm和8.9cm。
- 无深静脉血栓或肺栓塞发生,术后疼痛和轻度皮肤并发症多在1个月内缓解。
核心结论
- 早期1940nm EVLA治疗儿童KTS有症状边缘静脉安全且高效,4年时肢体肥大和生活质量改善持续存在。
研究设计与样本
- 回顾性单臂队列研究,在三级大学医院开展,纳入44例儿童KTS患者(平均年龄12.5岁),行1940nm波长EVLA(4-6W,50-70J/cm),随访4年。
主要发现
- 技术成功率为100%(44/44)。
- 术后疼痛发生率90.9%,轻度皮肤并发症发生率95.5%,均在1个月内几乎完全缓解(P<.001)。
- 平均静脉生活质量评分从828.4(标准差93.95)升至4年时的1562.1(标准差162.40)(P<.001)。
- 腿围和大腿围分别减少8.1cm和8.9cm(P<.001)。
- 晚期再通率为4.5%,未记录到深静脉血栓或肺栓塞。
临床怎么用
- 对于儿童KTS有症状的边缘静脉功能不全,可考虑采用1940nm波长EVLA进行早期干预。
- 术后需关注疼痛和轻度皮肤并发症,但多在1个月内缓解。
- 长期随访中需监测晚期再通,本研究报告再通率为4.5%。
局限性
- 本研究为回顾性单臂队列设计,无对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Symptomatic marginal veins and progressive limb overgrowth are the hallmarks of Klippel-Trenaunay syndrome (KTS) and other phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum disorders. Data on endovenous laser ablation (EVLA) with modern wavelengths in pediatric populations with long-term follow-up remain limited. METHODS: This retrospective single-arm cohort study was conducted at a tertiary university hospital. Forty-four pediatric patients with KTS (mean age, 12.5 years) with symptomatic marginal vein incompetence underwent EVLA with 1940-nm wavelength (4-6 W, 50-70 J/cm). Technical success, adverse events, limb circumference, vein quality-of-life scores, and reintervention rates were assessed over 4 years. RESULTS: The technical success rate was 100% (44/44). Postprocedural pain (90.9%) and mild skin complications (95.5%) resolved almost entirely within 1 month (P < .001). The mean vein quality-of-life scores increased from 828.4 (standard deviation, 93.95) to 1562.1 (standard deviation, 162.40) at 4 years (P < .001). The leg and thigh circumferences decreased by 8.1 cm and 8.9 cm, respectively (P < .001). Late recanalization occurred in 4.5% of patients. No deep vein thrombosis or pulmonary embolism was recorded. CONCLUSIONS: In this retrospective analysis, early 1940-nm EVLA for symptomatic marginal veins in pediatric KTS appears safe and highly effective, with sustained improvements in limb hypertrophy and quality of life at 4 years.
引用
- Mahmoud AA, Basta MGZ, Hagag MA, et al. Early endovenous laser ablation with 1940-nm wavelength for symptomatic marginal veins in pediatric Klippel-Trenaunay syndrome: A 4-year retrospective cohort study on safety, limb hypertrophy, and quality of life. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42697435. doi:10.1016/j.jvsv.2026.102614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。